Kynurenine pathway in psychosis: evidence of increased tryptophan degradation

Scale for the Assessment of Negative Symptoms (SANS)*

(1989) · The British Journal of Psychiatry · doi:10.1192/s0007125000291502 · Cited by 2,706 · see citing works

Scale for Assessment of Positive Symptoms (SAPS) 1984

Andreasen, N. C. (1995) · Open Scholarship Institutional Repository (Washington University in St. Louis) · Cited by 2,423 · see citing works

Quinolinic Acid: An Endogenous Metabolite That Produces Axon-Sparing Lesions in Rat Brain

Schwarcz, R. M., Whetsell, W. O., & Mangano, R. M. (1983) · Science · doi:10.1126/science.6849138 · Cited by 1,269 · see citing works

Assessing Depression in Schizophrenia: The Calgary Depression Scale

Addington, D. E., Addington, J., & Maticka‐Tyndale, E. (1993) · The British Journal of Psychiatry · doi:10.1192/s0007125000292581 · Cited by 1,177 · see citing works

Tryptophan-derived Catabolites Are Responsible for Inhibition of T and Natural Killer Cell Proliferation Induced by Indoleamine 2,3-Dioxygenase

Frumento, G., Rotondo, R., Tonetti, M., Damonte, G., Benatti, U., & Ferrara, G. B. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020121 · Cited by 1,133 · see citing works

Relationship between interferon‐γ, indoleamine 2,3‐dioxygenase, and tryptophan catabolism

Taylor, M. W., & Feng, G. (1991) · The FASEB Journal · doi:10.1096/fasebj.5.11.1907934 · Cited by 1,060 · see citing works

Neuropharmacology of quinolinic and kynurenic acids.

Stone, T. W. (1993) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00441-7 · Cited by 949 · see citing works

Blood–Brain Barrier Transport of Kynurenines: Implications for Brain Synthesis and Metabolism

Fukui, S., Schwarcz, R. M., Rapoport, S. I., Takada, Y., & Smith, Q. R. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb03460.x · Cited by 765 · see citing works

Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia

Kim, J. S., Kornhuber, H. H., Schmid‐Burgk, W., & Holzmüller, B. (1980) · Neuroscience Letters · doi:10.1016/0304-3940(80)90178-0 · Cited by 694 · see citing works

Increased cortical kynurenate content in schizophrenia

Schwarcz, R., Rassoulpour, A., Wu, H.-Q., Medoff, D., Tamminga, C. A., & Roberts, R. C. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01078-2 · Cited by 590 · see citing works

Manipulation of Brain Kynurenines: Glial Targets, Neuronal Effects, and Clinical Opportunities

Schwarcz, R. M., & Pellicciari, R. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.034439 · Cited by 556 · see citing works

Monitoring tryptophan metabolism in chronic immune activation

Schröcksnadel, K., Wirleitner, B., Winkler, C., & Fuchs, D. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2005.06.013 · Cited by 551 · see citing works

Kynurenine pathway in major depression: Evidence of impaired neuroprotection

Myint, A.-M., Kim, Y. K., Verkerk, R., Scharpé, S., Steinbusch, H., & Leonard, B. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2006.07.013 · Cited by 527 · see citing works

Human macrophages convert l -tryptophan into the neurotoxin quinolinic acid

Heyes, M. P., Saito, K., & Markey, S. P. (1992) · Biochemical Journal · doi:10.1042/bj2830633 · Cited by 448 · see citing works

Tryptophan metabolism and brain function: focus on kynurenine and other indole metabolites

Moroni, F. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00196-x · Cited by 347 · see citing works

Depression in first-episode schizophrenia

Koreen, A., Siris, S. G., Chakos, M., Alvir, J. M., Mayerhoff, D. I., & Lieberman, J. A. (1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.11.1643 · Cited by 319 · see citing works

l-Kynurenine Its synthesis and possible regulatory function in brain

G�l, E. M., & Sherman, A. D. (1980) · Neurochemical Research · doi:10.1007/bf00964611 · Cited by 318 · see citing works

Tryptophan degradation and immune activation in Alzheimer's disease

Widner, B., Leblhuber, F., Walli, J., Tilz, G. P., Demel, U., & Fuchs, D. (2000) · Journal of Neural Transmission · doi:10.1007/s007020050029 · Cited by 287 · see citing works

Nicotinic Receptor Function in Schizophrenia

Leonard, S. S., Adams, C., Breese, C. R., Adler, L. E., Bickford, P. C., Byerley, W., Coon, H. H., Griffith, J. M., Miller, C., Myles‐Worsley, M., et al. (1996) · Schizophrenia Bulletin · doi:10.1093/schbul/22.3.431 · Cited by 263 · see citing works

Molecules in focus: Indoleamine 2,3-dioxygenase

King, N. J. C., & Thomas, S. R. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.01.004 · Cited by 260 · see citing works

Human microglia convert l -tryptophan into the neurotoxin quinolinic acid

Heyes, M. P., Achim, C. L., Wiley, C. A., Major, E. O., Saito, K., & Markey, S. P. (1996) · Biochemical Journal · doi:10.1042/bj3200595 · Cited by 260 · see citing works

Upregulation of the initiating step of the kynurenine pathway in postmortem anterior cingulate cortex from individuals with schizophrenia and bipolar disorder

Miller, C. L., Llenos, I. C., Dulay, J. R., & Weis, S. (2006) · Brain Research · doi:10.1016/j.brainres.2005.12.056 · Cited by 240 · see citing works

Enzymology of Nad + Synthesis

Magni, G., Amici, A., Emanuelli, M., Raffaelli, N., & Ruggieri, S. (1999) · Advances in enzymology and related areas of molecular biology/Advances in enzymology and related subjects · doi:10.1002/9780470123195.ch5 · Cited by 235 · see citing works

Expression of the kynurenine pathway enzyme tryptophan 2,3-dioxygenase is increased in the frontal cortex of individuals with schizophrenia

Miller, C. L., Llenos, I. C., Dulay, J. R., Barillo, M. M., Yolken, R. H., & Weis, S. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.12.015 · Cited by 232 · see citing works

Different kynurenine pathway enzymes limit quinolinic acid formation by various human cell types

Heyes, M. P., Chen, C. Y., Major, E. O., & Saito, K. (1997) · Biochemical Journal · doi:10.1042/bj3260351 · Cited by 215 · see citing works

Schizophrenia as an inflammation-mediated dysbalance of glutamatergic neurotransmission

Müller, N., & Schwarz, M. (2006) · Neurotoxicity Research · doi:10.1007/bf03033242 · Cited by 214 · see citing works

Review of immunological and immunopathological findings in schizophrenia.

Rothermundt, M., Arolt, V., & Bayer, T. (2001) · Brain, behavior, and immunity · doi:10.1006/brbi.2001.0648 · Cited by 200 · see citing works

A mechanism for increased quinolinic acid formation following acute systemic immune stimulation.

Saito, K., Crowley, J. S., Markey, S., & Heyes, M. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82284-0 · Cited by 194 · see citing works

Determination of tryptophan and its kynurenine pathway metabolites in human serum by high-performance liquid chromatography with simultaneous ultraviolet and fluorimetric detection

Hervé, C., Beyne, P., Jamault, H., & Delacoux, E. (1996) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/0378-4347(95)00341-x · Cited by 186 · see citing works

Induction of Tryptophan Degradation In Vitro and In Vivo : A γ-Interferon-Stimulated Activity

Byrne, G. I., LEHMANN, L. K., KIRSCHBAUM, J. G., Borden, E. C., Lee, C. M., & Brown, R. R. (1986) · Journal of Interferon Research · doi:10.1089/jir.1986.6.389 · Cited by 183 · see citing works

Role of IFN-gamma-induced indoleamine 2,3 dioxygenase and inducible nitric oxide synthase in the replication of human cytomegalovirus in retinal pigment epithelial cells.

Bodaghi, B., Goureau, O., Zipeto, D., Laurent, L., Virelizier, J. L., & Michelson, S. (1999) · PubMed · Cited by 180 · see citing works

Dramatic changes in oxidative tryptophan metabolism along the kynurenine pathway in experimental cerebral and noncerebral malaria.

Sanni, L. A., Thomas, S. R., Tattam, B. N., Moore, D. E., Chaudhri, G., Stocker, R., & Hunt, N. H. (1998) · Europe PMC (PubMed Central) · Cited by 178 · see citing works

The role of immune function in schizophrenia: an overview

Müller, N., Riedel, M. K. M., Ackenheil, M., & Schwarz, M. (1999) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/pl00014187 · Cited by 158 · see citing works

Effects of phencyclidine on excitatory amino acid activation of spinal interneurones in the cat

Lodge, D., & Anis, N. A. (1982) · European Journal of Pharmacology · doi:10.1016/0014-2999(82)90022-x · Cited by 158 · see citing works

Role of IFN-γ-Induced Indoleamine 2,3 Dioxygenase and Inducible Nitric Oxide Synthase in the Replication of Human Cytomegalovirus in Retinal Pigment Epithelial Cells

Bodaghi, B., Goureau, O., Zipeto, D., Laurent, L., Virelizier, J., & Michelson, S. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.2.957 · Cited by 154 · see citing works

Micromolar Brain Levels of Kynurenic Acid are Associated with a Disruption of Auditory Sensory Gating in the Rat

Shepard, P. D., Joy, B., Prendeville, L. C., & Schwarcz, R. M. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300188 · Cited by 131 · see citing works

Biochemical and Medical Aspects of Tryptophan Metabolism

Nunn, P. B. (1981) · FEBS Letters · doi:10.1016/0014-5793(81)80451-6 · Cited by 105 · see citing works

Brain tryptophan metabolism in schizophrenia: A post mortem study of metabolites on the serotonin and kynurenine pathways in schizophrenic and control subjects

Joseph, M. H., Baker, H. F., Crow, T. J., Riley, G. J., & Risby, D. (1979) · Psychopharmacology · doi:10.1007/bf00431959 · Cited by 80 · see citing works

Quantification of Local De Novo Synthesis Versus Blood Contributions to Quinolinic Acid Concentrations in Brain and Systemic Tissues

Heyes, M. P., & Morrison, P. F. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68010280.x · Cited by 79 · see citing works

Kynurenic acid antagonists and kynurenine pathway inhibitors

Stone, T. W. (2001) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.10.4.633 · Cited by 79 · see citing works

Purine, Kynurenine, Neopterin and Lipid Peroxidation Levels in Inflammatory Bowel Disease

Forrest, C. M., Youd, P. L., Kennedy, A., Gould, S. R., Darlington, L. G., & Stone, T. W. (2002) · Journal of Biomedical Science · doi:10.1007/bf02256538 · Cited by 77 · see citing works

IDO induction in IFN-γ activated astroglia: A role in improving cell viability during oxidative stress

Grant, R., Naif, H. M., Espinosa, M., & Kapoor, V. (2000) · Redox Report · doi:10.1179/135100000101535357 · Cited by 76 · see citing works

Kynurenic Acid And Schizophrenia

Erhardt, S., Schwieler, L., & Engberg, G. (2003) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0135-0_18 · Cited by 74 · see citing works

Chronic neuroleptic treatment reduces endogenous kynurenic acid levels in rat brain

Ceresoli‐Borroni, G., Rassoulpour, A., Wu, H., Guidetti, P., & Schwarcz, R. M. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-005-0432-z · Cited by 72 · see citing works

Increased Th1 and Th2 immune reactivity with relative Th2 dominance in patients with acute exacerbation of schizophrenia.

Avguštin, B., Wraber, B., & Tavčar, R. (2005) · PubMed · Cited by 65 · see citing works

The regulation of rat liver tryptophan pyrrolase activity by reduced nicotinamide-adenine dinucleotide (phosphate). Experiments with glucose and nicotinamide

Badawy, A. A. ‐., & Evans, M. (1976) · Biochemical Journal · doi:10.1042/bj1560381 · Cited by 55 · see citing works

Biochemical and medical aspects of tryptophan metabolism.

Hayaishi, O., Ishimura, Y., & Kido, R. (1980) · Cited by 53 · see citing works

Acute tryptophan depletion in schizophrenia

GOLIGHTLY, K. L., LLOYD, J. A., HOBSON, J. E., Gallagher, P., Mercer, G., & Young, A. H. (2001) · Psychological Medicine · doi:10.1017/s0033291799003062 · Cited by 46 · see citing works

Enzyme activities of tryptophan metabolism along the kynurenine pathway in various species of animals.

Allegri, G., Costa, C., Bertazzo, A., Biasiolo, M., & Ragazzi, E. (2003) · Il Farmaco · doi:10.1016/s0014-827x(03)00140-x · Cited by 43 · see citing works

Acute Dietary Tryptophan Depletion: Effects on Schizophrenic Positive and Negative Symptoms

Sharma, R. P., Shapiro, L. E., Kamath, S. K., Soll, E. A., Watanabe, M. D., & Davis, J. M. (2008) · Neuropsychobiology · doi:10.1159/000119323 · Cited by 30 · see citing works

Induction of indoleamine 2,3-dioxygenase in primary human macrophages by HIV-1

Grant, R., Naif, H. M., Thuruthyil, S. J., Nasr, N., Littlejohn, T. K., Takikawa, O., & Kapoor, V. (2000) · Redox Report · doi:10.1179/135100000101535366 · Cited by 28 · see citing works

Depression in Kraepelinian schizophrenia

Kilzieh, N., Wood, A. E., Erdmann, J., Raskind, M. A., & Tapp, A. M. (2003) · Comprehensive Psychiatry · doi:10.1053/comp.2003.50002 · Cited by 24 · see citing works

Indoleamine 2,3-Dioxygenase

Ino, K., & Kikkawa, F. (2008) · Springer eBooks · doi:10.1007/978-3-540-47648-1_3037 · Cited by 2 · see citing works

Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects

Miller, B. J., Buckley, P., Seabolt, W., Mellor, A., & Kirkpatrick, B. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.04.013 · Cited by 1,742 · see citing works

A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression.

Goldsmith, D. R., Rapaport, M. H., & Miller, B. J. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.3 · Cited by 1,683 · see citing works

Diet and the Microbiota–Gut–Brain Axis: Sowing the Seeds of Good Mental Health

Berding, K., Vlckova, K., Marx, W., Schellekens, H., Stanton, C., Clarke, G., Jacka, F., Dinan, T. G., & Cryan, J. F. (2021) · Advances in Nutrition · doi:10.1093/advances/nmaa181 · Cited by 451 · see citing works

The role of pro-inflammatory cytokines in the neuroinflammation and neurogenesis of schizophrenia

Na, K., Jung, H., & Kim, Y. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.10.022 · Cited by 425 · see citing works

The kynurenine system and immunoregulation

Mándi, Y., & Vécsei, L. (2012) · Journal of neural transmission · doi:10.1007/s00702-011-0681-y · Cited by 382 · see citing works

Meta-analysis of Cerebrospinal Fluid Cytokine and Tryptophan Catabolite Alterations in Psychiatric Patients: Comparisons Between Schizophrenia, Bipolar Disorder, and Depression

Wang, A. K., & Miller, B. J. (2017) · Schizophrenia Bulletin · doi:10.1093/schbul/sbx035 · Cited by 389 · see citing works

Association of high-sensitivity C-reactive protein with <i>de novo</i> major depression

Pasco, J. A., Nicholson, G. C., Williams, L. J., Jacka, F. N., Henry, M. J., Kotowicz, M. A., Schneider, H. G., Leonard, B. E., & Berk, M. (2010) · British Journal of Psychiatry · doi:10.1192/bjp.bp.109.076430 · Cited by 321 · see citing works

The kynurenine pathway in major depressive disorder, bipolar disorder, and schizophrenia: a meta-analysis of 101 studies

Marx, W., McGuinness, A. J., Rocks, T., Ruusunen, A. A., Cleminson, J. R., Walker, A. J., Gomes‐da‐Costa, S., Lane, M. M., Sanches, M., Díaz, A. P., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-00951-9 · Cited by 327 · see citing works

Inflammation and Schizophrenia

Kirkpatrick, B. W., & Miller, B. J. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbt141 · Cited by 318 · see citing works

The Role of the Microbial Metabolites Including Tryptophan Catabolites and Short Chain Fatty Acids in the Pathophysiology of Immune-Inflammatory and Neuroimmune Disease

Morris, G., Berk, M., Carvalho, A. F., Caso, J. R., Sanz, Y., Walder, K. R., & Maes, M. H. J. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0004-2 · Cited by 307 · see citing works

Dysregulation of kynurenine metabolism is related to proinflammatory cytokines, attention, and prefrontal cortex volume in schizophrenia

Kindler, J., Lim, C. K., Weickert, C., Boerrigter, D., Galletly, C., Liu, D., Jacobs, K. R., Balzan, R., Bruggemann, J. M., O'Donnell, M., et al. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0401-9 · Cited by 267 · see citing works

Cross talk: the microbiota and neurodevelopmental disorders

Kelly, J. R., Minuto, C., Cryan, J. F., Clarke, G., & Dinan, T. G. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00490 · Cited by 271 · see citing works

Kynurenic Acid in Schizophrenia: A Systematic Review and Meta-analysis

Plitman, E., Iwata, Y., Caravaggio, F., Nakajima, S., Chung, J. K., Gerretsen, P., Kim, J., Takeuchi, H., Chakravarty, M. M., Remington, G. J., et al. (2017) · Schizophrenia Bulletin · doi:10.1093/schbul/sbw221 · Cited by 252 · see citing works

Is psychosis a multisystem disorder? A meta-review of central nervous system, immune, cardiometabolic, and endocrine alterations in first-episode psychosis and perspective on potential models

Pillinger, T., D’Ambrosio, E., McCutcheon, R., & Howes, O. D. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0058-9 · Cited by 230 · see citing works

Towards an Immunophenotype of Schizophrenia: Progress, Potential Mechanisms, and Future Directions

Miller, B. J., & Goldsmith, D. R. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.211 · Cited by 182 · see citing works

Genomics of schizophrenia: time to consider the gut microbiome?

Dinan, T. G., Borre, Y. E., & Cryan, J. F. (2014) · Molecular Psychiatry · doi:10.1038/mp.2014.93 · Cited by 175 · see citing works

The Role of Tryptophan Metabolites in Neuropsychiatric Disorders

Davidson, M., Rashidi, N., Nurgali, K., & Apostolopoulos, V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179968 · Cited by 180 · see citing works

The Role of Aberrations in the Immune-Inflammatory Response System (IRS) and the Compensatory Immune-Regulatory Reflex System (CIRS) in Different Phenotypes of Schizophrenia: the IRS-CIRS Theory of Schizophrenia

Roomruangwong, C., Noto, C. D. S., Kanchanatawan, B., Anderson, G., Kubera, M., Carvalho, A. F., & Maes, M. H. J. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01737-z · Cited by 162 · see citing works

Attention-deficit hyperactivity disorder (ADHD) and glial integrity: an exploration of associations of cytokines and kynurenine metabolites with symptoms and attention

Oades, R. D., Myint, A.-M., Dauvermann, M. R., SCHIMMELMANN, B. G., & Schwarz, M. (2010) · Behavioral and Brain Functions · doi:10.1186/1744-9081-6-32 · Cited by 148 · see citing works

Toxoplasma gondii antibody titers and history of suicide attempts in patients with schizophrenia

Okusaga, O. O., LANGENBERG, P. W., Sleemi, A., Vaswani, D., Giegling, I., Hartmann, A. M., Konte, B., Friedl, M., Groer, M. E., Yolken, R. H., et al. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.08.006 · Cited by 129 · see citing works

Effects of inflammation on the kynurenine pathway in schizophrenia—a systematic review

Pedraz-Petrozzi, B., Elyamany, O., Rummel, C., & Mulert, C. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-1721-z · Cited by 119 · see citing works

A systematic, quantitative review of blood autoantibodies in schizophrenia

Ezeoke, A., Mellor, A. L., Buckley, P. F., & Miller, B. J. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.07.029 · Cited by 115 · see citing works

The role of the gut microbiome in the development of schizophrenia

Kelly, J. R., Minuto, C., Cryan, J. F., Clarke, G. A., & Dinan, T. G. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.02.010 · Cited by 119 · see citing works

3-Hydroxykynurenine and clinical symptoms in first-episode neuroleptic-naive patients with schizophrenia

Condray, R., Dougherty, G. G., Keshavan, M. S., Reddy, R. D., Haas, G. L., Montrose, D. M., Matson, W. R., McEvoy, J. P., Kaddurah-Daouk, R. F., & Yao, J. K. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710001689 · Cited by 98 · see citing works

Clinical Implications of the Cytokine Hypothesis of Depression: The Association between Use of Statins and Aspirin and the Risk of Major Depression

Pasco, J. A., Jacka, F. N., Williams, L. J., Henry, M. J., Nicholson, G. C., Kotowicz, M. A., & Berk, M. (2010) · Psychotherapy and Psychosomatics · doi:10.1159/000319530 · Cited by 95 · see citing works

The Gut–Brain Axis in Schizophrenia: The Implications of the Gut Microbiome and SCFA Production

Ju, S., Shin, Y., Han, S., Kwon, J., Choi, T. G., Kang, I., & Kim, S. S. (2023) · Nutrients · doi:10.3390/nu15204391 · Cited by 95 · see citing works

Early developmental elevations of brain kynurenic acid impair cognitive flexibility in adults: Reversal with galantamine

Alexander, K., Pocivavsek, A., Wu, H., Pershing, M. L., Schwarcz, R. M., & Bruno, J. P. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.01.063 · Cited by 85 · see citing works

The relationship between nicotine and psychosis

Quigley, H., & MacCabe, J. H. (2019) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125319859969 · Cited by 90 · see citing works

Gut microbiota, kynurenine pathway and mental disorders – Review

Więdłocha, M., Marcinowicz, P., Janoska-Jaździk, M., & Szulc, A. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110145 · Cited by 87 · see citing works

The tryptophan catabolite or kynurenine pathway in schizophrenia: meta-analysis reveals dissociations between central, serum, and plasma compartments

Almulla, A. F., Vasupanrajit, A., Tunvirachaisakul, C., Al‐Hakeim, H. K., Solmi, M., Verkerk, R. M., & Maes, M. H. J. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01552-4 · Cited by 84 · see citing works

Tryptophan Metabolism and White Matter Integrity in Schizophrenia

Chiappelli, J., Postolache, T. T., Kochunov, P. V., Rowland, L. M., Wijtenburg, S. A., Shukla, D. K., Tagamets, M. A., Du, X. M., Savransky, A., Lowry, C. A., et al. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.66 · Cited by 84 · see citing works

Dysregulation of kynurenine pathway and potential dynamic changes of kynurenine in schizophrenia: A systematic review and meta-analysis.

Cao, B., Chen, Y., Ren, Z., Pan, Z., McIntyre, R., & Wang, D. (2021) · Neuroscience and Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.01.018 · Cited by 65 · see citing works

Tryptophan degradation in women with breast cancer: a pilot study

Lyon, D., Walter, J. M., Starkweather, A. R., Schubert, C. M., & McCain, N. L. (2011) · BMC Research Notes · doi:10.1186/1756-0500-4-156 · Cited by 71 · see citing works

The immune-kynurenine pathway in social anxiety disorder

Butler, M., Long-Smith, C. M., Moloney, G. M., Mörkl, S., O’Mahony, S. M., Cryan, J. F., Clarke, G. A., & Dinan, T. G. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.10.020 · Cited by 67 · see citing works

The association of the kynurenine pathway of tryptophan metabolism with acute brain dysfunction during critical illness*

Wilson, J. R. A., Morandi, A., Girard, T., Thompson, J. L., Boomershine, C. S., Shintani, A., Ely, E. W., & Pandharipande, P. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e318236f62d · Cited by 58 · see citing works

The role of microbiota in the pathogenesis of schizophrenia and major depressive disorder and the possibility of targeting microbiota as a treatment option

Feng-li, L., Chen, S., Wang, L., Jiang, R., Tian, H., Li, J., Yao, Y., & Zhuo, C. (2017) · Oncotarget · doi:10.18632/oncotarget.21284 · Cited by 66 · see citing works

Deficit, but Not Nondeficit, Schizophrenia Is Characterized by Mucosa-Associated Activation of the Tryptophan Catabolite (TRYCAT) Pathway with Highly Specific Increases in IgA Responses Directed to Picolinic, Xanthurenic, and Quinolinic Acid

Kanchanatawan, B., Sirivichayakul, S., Ruxrungtham, K., Carvalho, A. F., Geffard, M., Ormstad, H., Anderson, G., & Maes, M. H. J. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0417-6 · Cited by 65 · see citing works

Analysis of gut microbiota and their metabolic potential in patients with schizophrenia treated with olanzapine: results from a six-week observational prospective cohort study

Pełka-Wysiecka, J., Kaczmarczyk, M., Bąba-Kubiś, A., Liśkiewicz, P., Wroński, M., Skonieczna-Żydecka, K., Marlicz, W., Misiak, B., Starzyńska, T., Kucharska-Mazur, J., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8101605 · Cited by 59 · see citing works

Identification and characterization of novel variants of the tryptophan 2,3-dioxygenase gene: Differential regulation in the mouse nervous system during development

Kanai, M., Nakamura, T., & Funakoshi, H. (2009) · Neuroscience Research · doi:10.1016/j.neures.2009.02.004 · Cited by 55 · see citing works

Two complex genotypes relevant to the kynurenine pathway and melanotropin function show association with schizophrenia and bipolar disorder

Miller, C. L., Murakami, P. N., Ruczinski, I., Ross, R. G., Sinkus, M. L., Sullivan, B. F., & Leonard, S. S. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.05.014 · Cited by 55 · see citing works

Correlations of Kynurenic Acid, 3-Hydroxykynurenine, sIL-2R, IFN-α, and IL-4 with Clinical Symptoms During Acute Relapse of Schizophrenia

Szymona, K., Zdzisińska, B., Karakuła‐Juchnowicz, H., Kocki, T., Kandefer‐Szerszeń, M., Flis, M., Rosa, W., & Urbańska, E. M. (2017) · Neurotoxicity Research · doi:10.1007/s12640-017-9714-0 · Cited by 53 · see citing works

Fecal microbiota transplantation in non-communicable diseases: Recent advances and protocols

Hamamah, S., Gheorghita, R. E., Lobiuc, A., Sîrbu, I. O., & Covașă, M. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.1060581 · Cited by 53 · see citing works

Physio-somatic symptoms in schizophrenia: association with depression, anxiety, neurocognitive deficits and the tryptophan catabolite pathway

Kanchanatawan, B., Sirivichayakul, S., Thika, S., Ruxrungtham, K., Carvalho, A. F., Geffard, M., Anderson, G., Noto, C. D. S., Ivanova, R., & Maes, M. H. J. (2017) · Metabolic Brain Disease · doi:10.1007/s11011-017-9982-7 · Cited by 51 · see citing works

An exploration of the associations of pregnancy and perinatal features with cytokines and tryptophan/kynurenine metabolism in children with attention-deficit hyperactivity disorder (ADHD)

Oades, R. D. (2011) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-011-0062-2 · Cited by 51 · see citing works

Exposure to Kynurenic Acid During Adolescence Produces Memory Deficits in Adulthood

Akagbosu, C., Evans, G. C., Gulick, D., Suckow, R. F., & Bucci, D. J. (2010) · Schizophrenia Bulletin · doi:10.1093/schbul/sbq151 · Cited by 50 · see citing works

Influence of plasma cytokines on kynurenine and kynurenic acid in schizophrenia

Chiappelli, J., Notarangelo, F. M., Pocivavsek, A., Thomas, M. A. R., Rowland, L., Schwarcz, R., & Hong, L. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0038-4 · Cited by 46 · see citing works

Decreased plasma tryptophan and tryptophan/large neutral amino acid ratio in patients with neuroleptic-resistant schizophrenia: relationship to plasma cortisol concentration.

Lee, M., Jayathilake, K., Dai, J., & Meltzer, H. (2011) · Psychiatry Research · doi:10.1016/j.psychres.2010.07.013 · Cited by 45 · see citing works

C-Reactive Protein Correlates with Negative Symptoms in Patients with Schizophrenia

Boozalis, T., Teixeira, A. L., Cho, R. Y.-J., & Okusaga, O. O. (2018) · Frontiers in Public Health · doi:10.3389/fpubh.2017.00360 · Cited by 45 · see citing works

Metabolomics in patients with psychosis: A systematic review

Li, C., Wang, A., Wang, C., Ramamurthy, J., Zhang, E. R., Guadagno, E., & Trakadis, Y. J. (2018) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32662 · Cited by 45 · see citing works

Serum Tryptophan, Tryptophan Catabolites and Brain-derived Neurotrophic Factor in Subgroups of Youngsters with Autism Spectrum Disorders

Ormstad, H., Bryn, V., Verkerk, R. M., Skjeldal, O. H., Halvorsen, B. L., Saugstad, O. D., Isaksen, J., & Maes, M. H. J. (2018) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527317666180720163221 · Cited by 43 · see citing works

Increased Plasma Kynurenic Acid Levels are Associated with Impaired Attention/Vigilance and Social Cognition in Patients with Schizophrenia

Huang, X., Ding, W., Wu, F., Zhou, S., Deng, S., & Ning, Y. (2020) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s239763 · Cited by 43 · see citing works

Effects of neuroactive metabolites of the tryptophan pathway on working memory and cortical thickness in schizophrenia

Huang, J., Tong, J., Zhang, P., Zhou, Y., Cui, Y., Tan, S., Wang, Z., Yang, F., Kochunov, P. V., Chiappelli, J., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01311-z · Cited by 41 · see citing works

Associations between expression of indoleamine 2, 3-dioxygenase enzyme and inflammatory cytokines in patients with first-episode drug-naive Schizophrenia

Zhang, Y., Shi, H., Yang, G., Yang, Y., Li, W., Song, M., Shao, M., Su, X., & Lv, L. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01688-x · Cited by 37 · see citing works

Social isolation rearing in rats alters plasma tryptophan metabolism and is reversed by sub-chronic clozapine treatment

Möller, M., du Preez, J. L., Emsley, R. A., & Harvey, B. H. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.02.021 · Cited by 36 · see citing works

Is T ‐helper type 2 shift schizophrenia‐specific? Primary results from a comparison of related psychiatric disorders and healthy controls

Chiang, S. S. W., Riedel, M. J., Schwarz, M., & Mueller, N. (2013) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12040 · Cited by 35 · see citing works

Blood-based kynurenine pathway alterations in schizophrenia spectrum disorders: A meta-analysis

Morrens, M., Picker, L. D., Kampen, J. K., & Coppens, V. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.09.007 · Cited by 35 · see citing works

New promises for manipulation of kynurenine pathway in cancer and neurological diseases

Costantino, G. (2009) · Expert opinion on therapeutic targets · doi:10.1517/14728220802665734 · Cited by 37 · see citing works

Physical Illnesses Before Diagnosed as Schizophrenia: A Nationwide Case-Control Study

Chen, Y., Pan, C., Chang, C.-K., Chen, P., Chang, H., Tai, M.-H., Su, S., Tsai, S., Chen, C., & Kuo, C. (2020) · Schizophrenia Bulletin · doi:10.1093/schbul/sbaa009 · Cited by 34 · see citing works

Kynurenine pathway abnormalities are state-specific but not diagnosis-specific in schizophrenia and bipolar disorder

Skorobogatov, K., Autier, V., Foiselle, M., Richard, J., Boukouaci, W., Wu, C., Raynal, S., Carbonne, C., Laukens, K., Meysman, P., et al. (2023) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2022.100584 · Cited by 33 · see citing works

Depressive, anxiety and hypomanic symptoms in schizophrenia may be driven by tryptophan catabolite (TRYCAT) patterning of IgA and IgM responses directed to TRYCATs

Kanchanatawan, B., Sirivichayakul, S., Carvalho, A. F., Anderson, G., Gałecki, P., & Maes, M. H. J. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.06.033 · Cited by 24 · see citing works

Kynurenine is correlated with IL-1β in plasma of schizophrenia patients

Joaquim, H. P. G., Costa, A. C., Gattaz, W. F., & Talib, L. L. (2018) · Journal of Neural Transmission · doi:10.1007/s00702-018-1838-8 · Cited by 24 · see citing works

Metabolomic profiling of the effects of allopurinol on Drosophila melanogaster

Bratty, M. A., Hobani, Y. H., Dow, J. A. T., & Watson, D. G. (2011) · Metabolomics · doi:10.1007/s11306-011-0275-6 · Cited by 22 · see citing works

Investigating the Impacts of Diet, Supplementation, Microbiota, Gut–Brain Axis on Schizophrenia: A Narrative Review

Zajkowska, I., Niczyporuk, P., Urbaniak, A. D., Tomaszek, N., Modzelewski, S., & Waszkiewicz, N. (2024) · Nutrients · doi:10.3390/nu16142228 · Cited by 21 · see citing works

Elevated serum kynurenic acid in individuals with first-episode psychosis and insufficient response to antipsychotics

Hatzimanolis, A., Foteli, S., Xenaki, L., Selaković, M., Dimitrakopoulos, S., Vlachos, I. I., Kosteletos, I., Soldatos, R. F., Gazouli, M., Chatzipanagiotou, S., et al. (2024) · Schizophrenia · doi:10.1038/s41537-024-00483-z · Cited by 19 · see citing works

Tryptophan Challenge in Healthy Controls and People with Schizophrenia: Acute Effects on Plasma Levels of Kynurenine, Kynurenic Acid and 5-Hydroxyindoleacetic Acid

Sathyasaikumar, K. V., Notarangelo, F. M., Kelly, D. L., Rowland, L. M., Hare, S., Chen, S., Chen, M., Buchanan, R. W., & Schwarcz, R. M. (2022) · Pharmaceuticals · doi:10.3390/ph15081003 · Cited by 18 · see citing works

Normative Data on Serum and Plasma Tryptophan and Kynurenine Concentrations from 8089 Individuals Across 120 Studies: A Systematic Review and Meta-Analysis

Metri, N., Butt, A. S., Murali, A., Steiner, G. Z., & Lim, C. K. (2023) · International Journal of Tryptophan Research · doi:10.1177/11786469231211184 · Cited by 16 · see citing works

The Role of Aberrations in the Immune-inflammatory Reflex System (IRS) and the Compensatory Immune-regulatory Reflex System (CIRS) in Different Phenotypes of Schizophrenia: The IRS-CIRS Theory of SchizophreniaPreprint

Roomruangwong, C., Noto, C. D. S., Kanchanatawan, B., Anderson, G., Kubera, M., Carvalho, A. F., & Maes, M. H. J. (2018) · Preprints.org · doi:10.20944/preprints201809.0289.v1 · Cited by 15 · see citing works

Novel nutritional treatment for manic and psychotic disorders: a review of tryptophan and tyrosine depletion studies and the potential of protein-based formulations using glycomacropeptide

Badawy, A. A. ‐. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3191-9 · Cited by 15 · see citing works

Preliminary comparative analysis of kynurenine pathway metabolites in chronic ketamine users, schizophrenic patients, and healthy controls

Zhang, Z., Zhang, M., Luo, Y., Ni, X., Lu, H., Wen, Y., & Fan, N. (2020) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2738 · Cited by 15 · see citing works

Decreased Plasma Levels of Kynurenine and Kynurenic Acid in Previously Treated and First-Episode Antipsychotic-Naive Schizophrenia Patients

Marković, M., Petronijević, N., Stašević, M., Karličić, I. S., Velimirović, M., Stojković, T., Ristić, S., Stojković, M., Milic, N. M., & Nikolić, T. (2023) · Cells · doi:10.3390/cells12242814 · Cited by 11 · see citing works

Indoleamine 2,3-dioxygenase (IDO)-activity in Severe Psychiatric Disorders: A Systemic Review

Fellendorf, F. T., Bonkat, N., Dalkner, N., Schönthaler, E. M. D., Manchia, M., Fuchs, D., & Reininghaus, E. Z. (2022) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026622666220718155616 · Cited by 12 · see citing works

Metabolic profiling study on potential toxicity in male mice treated with Dechlorane 602 using UHPLC-ESI-IT-TOF-MS

Tao, W., Tian, J., Xu, T., Xu, S. L., Xie, H. Q., Zhou, Z., Guo, Z., Fu, H., Yin, X., Chen, Y., et al. (2018) · Environmental Pollution · doi:10.1016/j.envpol.2018.11.086 · Cited by 12 · see citing works

METABOLISMO DO TRIPTOFANO EM TRANSTORNOS MENTAIS: UM ENFOQUE NA ESQUIZOFRENIA

Carvalho, M. S., Yonamine, C. M., Mas, C. D., Nunes, D. F. S., & Hayashi, M. A. F. (2017) · VITTALLE - Revista de Ciências da Saúde · doi:10.14295/vittalle.v29i2.6550 · Cited by 11 · see citing works

The tryptophan catabolite or kynurenine pathway in schizophrenia: meta-analysis reveals dissociations between central, serum and plasma compartmentsPreprint

Almulla, A. F., Vasupanrajit, A., Tunvirachaisakul, C., Al‐Hakeim, H. K., Solmi, M., Verkerk, R. M., & Maes, M. H. J. (2021) · medRxiv · doi:10.1101/2021.12.16.21267905 · Cited by 10 · see citing works

Effects of chronic physical illness on treatment outcomes among patients with schizophrenia

Filipčić, I. Š., Bajić, Ž., & Filipčić, I. (2019) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000532 · Cited by 10 · see citing works

Serum kynurenine metabolites might not be associated with risk factors of treatment-resistant schizophrenia

Huang, J., Zhang, P., Zhou, Y., Tong, J., Cui, Y., Tan, S., Wang, Z., Yang, F., Kochunov, P. V., Tian, B., et al. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.11.002 · Cited by 9 · see citing works

Role and mechanism of gut microbiota and metabolites in schizophrenia complicated with sleep disorder

Huang, Z., Huang, Z., Du, Z., Gao, X., Jiang, Y., Zhou, Z., & Zhu, H. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2607817 · Cited by 9 · see citing works

Tryptophan Metabolism and the Microbiome-Gut-Brain Axis

Clarke, G. A., Villalobos-Manríquez, F., & Marin, D. C. (2021) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780190931544.013.13 · Cited by 7 · see citing works

Hematological and inflammatory markers in Han Chinese patients with drug-free schizophrenia: relationship with symptom severity

Yang, C., Tian, Y., Yang, X., Liu, L., Chen, L., Xia, L., & Liu, H. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1337103 · Cited by 7 · see citing works

Kynurenines Dynamics in the Periphery and Central Nervous System Steers Behavioral Deficits in Rats under Hypobaric Hypoxia.

Verma, K., Amitabh, Prasad, D., Reddy, M. P., & Kohli, E. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00632 · Cited by 5 · see citing works

Is Relapse in Schizophrenia an Immune-Mediated Effect?

Miller, B. J., & Buckley, P. F. (2012) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.10.2.115 · Cited by 6 · see citing works

Influence of pregnancy and non-fasting conditions on the plasma metabolome in a rat prenatal toxicity study

Ramirez‐Hincapie, S., Giri, V., Keller, J., Kamp, H., Haake, V., Richling, E., & van Ravenzwaay, B. (2021) · Archives of Toxicology · doi:10.1007/s00204-021-03105-0 · Cited by 5 · see citing works

In vivo type II T-helper cells shift in schizophrenia compared to sex- and age-matched healthy controls

Chiang, S. S. W., Riedel, M. J., Gruber, R., Müller, N., & Schwarz, M. (2011) · The European Journal of Psychiatry · doi:10.4321/s0213-61632011000400002 · Cited by 5 · see citing works

Şizofreni Etyolojisinde Mikrobiyotanın Rolü

Kartalcı, Ş. (2017) · Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry · doi:10.18863/pgy.358105 · Cited by 7 · see citing works

Destigmatising mental illness, House style

Amanullah, S. (2010) · The British Journal of Psychiatry · doi:10.1192/bjp.197.5.377 · Cited by 2 · see citing works

The Tryptophan Catabolite or Kynurenine Pathway in Schizophrenia: Meta-Analysis Reveals Dissociations Between Central, Serum and Plasma CompartmentsPreprint

Almulla, A. F., Vasupanrajit, A., Tunvirachaisakul, C., Al‐Hakeim, H. K., Solmi, M., Verkerk, R. M., & Maes, M. H. J. (2021) · Preprints.org · doi:10.20944/preprints202112.0301.v1 · Cited by 2 · see citing works

Sex-specific association of IDO1 gene with schizophrenia and imbalanced levels of cytokines and neuroactive kynurenine metabolites in relapsed patients

Afia, A. B., MacDowell, K. S., Martín‐Hernández, D., Zaafrane, F., Gaha, L., Leza, J. C., & Jrad, B. B. H. (2025) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-025-02172-z · Cited by 1 · see citing works

Metaanálisis de los estudios publicados sobre alteraciones de los valores de las citocinas en la esquizofrenia: efectos del estado clínico y de los antipsicóticos

Miller, B. J., Buckley, P. F., Seabolt, W., Mellor, A. L., & Kirkpatrick, B. W. (2011) · Psiquiatría Biológica · doi:10.1016/j.psiq.2011.10.006 · Cited by 1 · see citing works

Metabolismo de triptofano na vigência de choque endotóxico induzido por LPS e hipertriptofanemia

Migliorini, S. (2011) · doi:10.11606/d.9.2011.tde-15072011-104933

Quinolinate and related excitotoxins: mechanisms of neurotoxicity and disease relevance

Addae, J., & Stone, T. (2014) · Springer eBooks · doi:10.1007/978-1-4614-5836-4_127 · Cited by 8 · see citing works

endotóxico induzido por LPS e hipertriptofanemia

Migliorini, S. (2010)

Current awareness in human psychopharmacology

(2009) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.978

Skin-Gut-Breast Microbiota Axes

Drago, L. (2021) · MDPI eBooks · doi:10.3390/books978-3-0365-0899-3

Is there any relationship between serum leptin and tryptophan levels and depression and anxiety in obese patients?

VELİOĞLU, Z., Yıldırım, D. İ., & Eryılmaz, M. A. (2022) · Troia Medical Journal · doi:10.55665/troiamedj.1118052

Régulation de la voie Kynurénine au cours de l’athérosclérose chez l'homme

Dongen, K. V. (2023) · doi:10.70675/e553eb8bz6e00z42f2z8c35z647b56bb3090

Peripheral Kynurenine-to-Tryptophan Ratio as a Candidate Biomarker of Early Neuroinflammatory Dysregulation in First-Episode Drug-Naive Psychosis: A Systematic Review and Meta-Analysis

Thirumalai, J., Mohammed, A. A. F., & Jeslin, G. N. (2026) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-026-02557-8

Kynurenine pathway metabolism and immune activation: Peripheral measurements in psychiatric and co-morbid conditions

Strasser, B., Becker, K., Fuchs, D., & Gostner, J. M. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.02.030 · Cited by 97 · see citing works

Kynurenine Pathway of Tryptophan Metabolism in Neuropsychiatric Disorders: Pathophysiologic and Therapeutic Considerations

Muneer, A. (2020) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2020.18.4.507 · Cited by 161 · see citing works

Kynurenic acid in brain function and dysfunction

Schwarcz, R. M., & Erhardt, S. (2020) · Oxford University Press eBooks · doi:10.1093/med/9780190653279.003.0036

Tryptophan breakdown pathway in bipolar mania

Myint, A.-M., Kim, Y., Verkerk, R. M., Park, S. H., Scharpé, S., Steinbusch, H. W. M., & Leonard, B. E. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2006.12.008 · Cited by 106 · see citing works

Alterations in kynurenine precursor and product levels in schizophrenia and bipolar disorder

Miller, C. L., Llenos, I. C., Cwik, M. F., Walkup, J. T., & Weis, S. (2008) · Neurochemistry International · doi:10.1016/j.neuint.2008.01.013 · Cited by 79 · see citing works